Stockscreener 앱 받기
6.35
3.93%
0.24
시간 외 거래:
6.27
-0.08
-1.26%
전일 마감가:
$6.11
열려 있는:
$6.15
하루 거래량:
10,701
Relative Volume:
0.23
시가총액:
$56.56M
수익:
$5.12M
순이익/손실:
$-67.00M
주가수익비율:
-4.3197
EPS:
-1.47
순현금흐름:
$-38.94M
1주 성능:
+12.59%
1개월 성능:
-26.33%
6개월 성능:
-4.28%
1년 성능:
-87.65%
1일 변동 폭
$6.0701
$6.45
1주일 범위
$5.49
$6.48
52주 변동 폭
$3.816
$58.20
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
명칭
Verrica Pharmaceuticals Inc
전화
484-453-3300
주소
10 NORTH HIGH STREET, WEST CHESTER, PA
VRCA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
6.35 | 56.56M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-06 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-25 | 업그레이드 | Needham | Hold → Buy |
| 2023-03-22 | 개시 | Jefferies | Buy |
| 2023-02-13 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-05-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-05-14 | 개시 | RBC Capital Mkts | Outperform |
| 2020-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-24 | 개시 | Northland Capital | Outperform |
| 2020-03-24 | 개시 | Needham | Buy |
| 2019-02-21 | 개시 | H.C. Wainwright | Buy |
모두보기
Verrica Pharmaceuticals Inc 주식(VRCA)의 최신 뉴스
Verrica VRCA 2025Q2 Earnings Preview Upside Potential on Strategic Expansion Plans - AInvest
Verrica Pharmaceuticals to Report Q2 Results on August 12 - MSN
Verrica Pharmaceuticals to Report Q2 2025 Financial Results and Provide Corporate Update on Aug 12, 2025. - AInvest
Verrica Pharmaceuticals to host Q2 earnings call on August 12, 2025. - AInvest
Verrica Pharmaceuticals: A Strategic Leap from Niche to Diversified Biotech Leader - AInvest
Verrica Pharmaceuticals to report second quarter 2025 financial results and provide a corporate update on August 12, 2025 - MarketScreener
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial - GuruFocus
Verrica Pharmaceuticals (VRCA): A Turning Point in 2025 Q2 Earnings and Strategic Momentum - AInvest
Verrica Pharmaceuticals to Report Second Quarter 2025 - GlobeNewswire
Verrica Pharmaceuticals Sets Q2 Earnings Date: Key Updates Expected on Dermatology Pipeline - Stock Titan
Common Warts Clinical Trials, Companies, Therapeutic - openPR.com
Common Warts Clinical Trials, Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, Pipeline Analysis | Verrica Pharmaceuticals, X4 Pharmaceuticals, Phio Pharmaceuticals, Kino Ph - Barchart.com
Verrica Pharmaceuticals Inc. Consolidation Zone May Signal AccumulationTrade Setups With Clear Risk Limits Highlighted - metal.it
Published on: 2025-08-04 09:22:19 - metal.it
What drives Verrica Pharmaceuticals Inc. stock priceAchieve rapid capital gains with smart investing - Jammu Links News
What makes Verrica Pharmaceuticals Inc. stock price move sharplyGet alerts on the hottest stocks daily - Jammu Links News
What analysts say about Verrica Pharmaceuticals Inc. stockAchieve consistent profits with disciplined trading - Jammu Links News
How volatile is Verrica Pharmaceuticals Inc. stock compared to the marketUnmatched profit potential - Jammu Links News
Is it the right time to buy Verrica Pharmaceuticals Inc. stockMaximize gains with proven stock analysis - Jammu Links News
Should I hold or sell Verrica Pharmaceuticals Inc. stock in 2025Unlock market-leading stock analysis - Jammu Links News
Why is Verrica Pharmaceuticals Inc. stock attracting strong analyst attentionOutstanding capital appreciation - Jammu Links News
What is the dividend policy of Verrica Pharmaceuticals Inc. stockOutperformance with explosive growth - Jammu Links News
What are the technical indicators suggesting about Verrica Pharmaceuticals Inc.Free Investment Community - Jammu Links News
How does Verrica Pharmaceuticals Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News
How many analysts rate Verrica Pharmaceuticals Inc. as a “Buy”Beginner Investor Insights That Work - jammulinksnews.com
What does recent volatility data suggest for Verrica Pharmaceuticals Inc.Minimal Risk Growth Investment Opportunity Analysis - Newser
Verrica Pharmaceuticals Implements Reverse Stock Split to Meet Nasdaq Requirements - AInvest
Leading vs lagging indicators on Verrica Pharmaceuticals Inc. performanceFree Multi-Bagger Potential Stock Forecast Tools - Newser
Market reaction to Verrica Pharmaceuticals Inc.’s recent newsSafe Investment Ideas with Growth Upside - Newser
Can machine learning forecast Verrica Pharmaceuticals Inc. recoveryAlgorithmic Prediction of Market Breakouts - Newser
Verrica Pharmaceuticals Implements Reverse Stock Split - TipRanks
Real time social sentiment graph for Verrica Pharmaceuticals Inc.Swing Setup With Technical Confirmation Explained - metal.it
Is Verrica Pharmaceuticals Inc. forming a bottoming baseTechnical Trade Plan with Entry Checklist - Newser
Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
MACD Signals Flash Warning for Verrica Pharmaceuticals Inc. StockConsistent Income Focused Trade List Analyzed - beatles.ru
What are Verrica Pharmaceuticals Inc. company’s key revenue driversCapital growth strategies that work - Jammu Links News
What are analysts’ price targets for Verrica Pharmaceuticals Inc. in the next 12 monthsFree Stock Selection - Jammu Links News
Is Verrica Pharmaceuticals Inc. a growth stock or a value stockFree Stock Movement Tracking - Jammu Links News
Verrica Pharmaceuticals Inc (VRCA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):